Antioxidant system in Down syndrome: a possible role in cataractogenesis

Area of Science:

• Biochemistry
• Ophthalmology
• Genetics

Background:

• Oxidative stress and antioxidant systems are linked to age-related degenerative diseases, including cataracts.
• Down syndrome (DS), caused by trisomy 21, is associated with increased free radical activity and specific ocular changes.
• Early cataract formation is a noted concern in individuals with Down syndrome.

Purpose of the Study:

• To investigate the activity of key antioxidant enzymes in patients with Down syndrome and cataracts.
• To explore the potential role of antioxidant system impairment in cataractogenesis in the DS population.

Main Methods:

• Serum samples were collected from 12 patients with Down syndrome and cataracts, and 12 age/sex-matched healthy controls.
• Erythrocyte levels of superoxide dismutase (SOD), glutathione peroxidase (GSHPx), glutathione-S-transferase (GST), and reduced glutathione (GSH) were measured.
• Enzyme activities were compared between the DS group and the control group.

Main Results:

• Significantly higher levels of superoxide dismutase (SOD) and glutathione peroxidase (GSHPx) were observed in patients with Down syndrome compared to controls.
• No significant differences in glutathione-S-transferase (GST) or reduced glutathione (GSH) levels were found between the groups.
• These findings indicate altered antioxidant enzyme activity in DS patients with cataracts.

Conclusions:

• The elevated SOD and GSHPx levels suggest a compensatory or dysregulated antioxidant response in Down syndrome.
• Impairment within the antioxidant system may be a contributing factor to the accelerated cataract development observed in individuals with Down syndrome.
• Further research is warranted to elucidate the precise mechanisms linking oxidative stress and cataractogenesis in DS.